Palantir Technologies Inc. v. Abramowitz

District Court, N.D. California·Decided June 11, 2021·No. 5:19-cv-06879·Unknown

Opinion

PALANTIR TECHNOLOGIES INC., Case No. 19-cv-06879-BLF

Plaintiff, ORDER GRANTING IN PART AND v. DENYING IN PART DEFENDANTS' MOTION TO DISMISS MARC L. ABRAMOWITZ, et al., [Re: ECF 127] Defendants.

Before the Court is a motion filed by Defendants Marc L. Abramowitz, KT4 Partners LLC (“KT4”), and Marc Abramowitz Charitable Trust No. 2 (“the Trust”) (collectively, “Defendants”) to dismiss the fifth amended complaint (“5AC”) filed by Plaintiff Palantir Technologies, Inc. (“Palantir”). See Mot. to Dismiss (“Mot.”), ECF 127. The Court held a hearing on the motion on March 4, 2021. For the reasons discussed below, Defendants’ motion to dismiss is GRANTED IN PART AND DENIED IN PART. I. BACKGROUND A. Factual Background Palantir is a data analytics company that was founded in 2003. Fifth Am. Compl. (“5AC”) ¶¶ 1, 16-17, ECF 126. To preserve its competitive advantage, Palantir allegedly places great emphasis on maintaining the secrecy of its proprietary information, and therefore its trade secrets constitute some of its most valuable assets. 5AC ¶¶ 2, 20. For example, Palantir allegedly restricts access to its sensitive internal information to employees with proper authorization and who need the information to perform their jobs. 5AC ¶ 20. Palantir also allegedly monitors its network for potential risks and protects its networks from unauthorized access. 5AC ¶ 20. Additionally, information to sign confidentiality agreements. 5AC ¶¶ 21-22. Marc Abramowitz is a private investor with no technical or engineering background. 5AC ¶¶ 3, 24. He became interested in Palantir in 2005, and he invested in the company through KT4 and the Trust, “two entities Abramowitz controls and uses to make investments and hold interests in companies with new or emerging technologies.” 5AC ¶¶ 3, 24. KT4 is a limited liability company that Abramowitz manages. 5AC ¶ 25. Abramowitz wholly owns a company with a 49% ownership in KT4, and the remaining 51% is owned by a handful of Abramowitz family trusts, including the Trust. 5AC ¶ 25. Abramowitz also administers the Trust and is its trustee and settlor. 5AC ¶ 25. Rather than personally invest in companies, Abramowitz uses the Trust and KT4 to invest in companies. 5AC ¶ 25. Abramowitz allegedly leveraged his investment in Palantir to position himself as a trusted advisor, agent, and fiduciary of Palantir. 5AC ¶¶ 4, 26. KT4 and the Trust’s investments in Palantir assured Palantir that Abramowitz would not betray its trust. 5AC ¶ 26. By 2012, as Palantir’s alleged agent, advisor, and fiduciary, Abramowitz allegedly was actively involved in Palantir’s day-to-day activities, frequently discussed Palantir’s business with company executives, worked or purported to work on various projects on behalf of Palantir, and purported to seek guidance from Palantir in connection with his work for the company. 5AC ¶ 27. Palantir alleges that between 2012 and 2014, it assented to Abramowitz acting as an agent on its behalf on several occasions, and Abramowitz allegedly agreed to be subject to Palantir’s supervision and control for these projects. 5AC ¶ 28. Palantir also alleges that Abramowitz advertised himself as Palantir’s “strategic advisor in the business development function.” 5AC ¶ 29. Between 2010 and 2015, Abramowitz visited Palantir’s offices on 60 occasions, held numerous offsite meetings, and even requested a permanent office at Palantir’s facilities. FAC ¶ 31. Palantir alleges that, because of Abramowitz’s promises to secure new lines of business for Palantir, find clients for Palantir’s products, and otherwise be helpful to Palantir, the company “invited Abramowitz into its inner circle and relaxed its ordinary care and vigilance with respect to outsiders precisely because Abramowitz held himself out to Palantir and others to be acting as Palantir’s proprietary information. 5AC ¶ 33. Palantir alleges that Abramowitz signed several confidentiality agreements that required him, KT4, and the Trust to safeguard Palantir’s confidential and proprietary information. 5AC ¶ 34. On August 14, 2012, Abramowitz, in his capacity as trustee of the Trust, electronically executed the Preferred Stock Transfer Agreement (the “2012 Transfer Agreement”), which memorializes the confidentiality obligations of the Trust and all “Covered Persons.” 5AC ¶ 35; see Mot., Ex. A, 2012 Transfer Agreement, ECF 127-2. The 2012 Transfer Agreement contains a section on confidentiality, which states, in relevant part: Each of Purchaser and Seller agrees to, and agrees to cause its respective Covered Persons to, keep confidential and refrain from using or disclosing all agreements, documents and other information regarding the Company or its securityholders provided or made available to Purchaser or Seller either (a) in connection with the exploration, negotiation, execution, and closing of this Agreement or (b) in its capacity as a stockholder of the Company following the date of this Agreement . . . . Each of Purchaser and Seller is responsible thereunder and shall be liable for any breaches of this Section 7 and any disclosure or misuse of any information or documents described in this section by its respective Covered Persons. 2012 Transfer Agreement § 7. On July 12, 2014, Abramowitz, in his personal capacity, electronically executed a Non- Disclosure Agreement (the “NDA”). 5AC ¶ 36; see Mot., Ex. C, NDA, ECF 127-4. Among other things, the NDA states that Abramowitz will “hold all Proprietary Information in strict confidence and will not use (except as expressly authorized by Palantir) or disclose any Proprietary Information for any purpose.” NDA ¶ 1. The NDA defines Proprietary Information as “non-public business, technical or other information, materials and/or ideas of Palantir,” which “shall include, without limitation, anything you learn or discover as a result of exposure to or analysis of any Proprietary Information.” NDA at 1. On July 17, 2015, Abramowitz, in his capacity as managing member of KT4, electronically executed a Preferred Stock Transfer Agreement (the “2015 Transfer Agreement”). 5AC ¶ 37; see Mot., Ex. B, 2015 Transfer Agreement, ECF 127-3. The 2015 Transfer Agreement memorializes the confidentiality obligations of both KT4 and all “Covered Persons.” 5AC ¶ 37. The 2015 Each of Purchaser and Seller agrees to, and agrees to cause its respective Covered Persons to, keep confidential and refrain from using or disclosing all agreements, documents and other information regarding the Company or its securityholders provided or made available to Purchaser or Seller either (a) in connection with the exploration, negotiation, execution, and closing of this Agreement or (b) in its capacity as a stockholder of the Company following the date of this Agreement, except (i) such information that is required to be provided to legal or accounting advisors to the Purchase and Seller . . . and (ii) any information that (A) is or becomes publicly available other than by breach of this provision by the Purchaser or Seller, . . . (B) was previously known to the Purchaser or Seller, as applicable, completely free of restrictions at the time of disclosure, or (C) was independently developed by the Purchaser or Seller . . . . Each of Purchaser and Seller is responsible hereunder and shall be liable for any breaches of this Section 7 and any disclosure or misuse of any information or documents described in this section by its respective Covered Persons. 2015 Transfer Agreement § 7. By the early 2010s, Palantir was expanding its technology to target: “(i) clinical drug trials and health insurance (the “Healthcare Technology”); (ii) cyber insurance and cyber security (the “Cyber Technology”); and (iii) natural resources exploration and management (the “Natural Resources Technology”). 5AC ¶ 39. Between 2012 and 2014, Abramowitz engaged in discussions with Palantir’s employees regarding these technologies and gained access to Palantir’s confidential and proprietary informati

Free access — add to your briefcase to read the full text and ask questions with AI

Palantir Technologies Inc. v. Abramowitz, (N.D. Cal. 2021).

Palantir Technologies Inc. v. Abramowitz (Palantir Technologies Inc. v. Abramowitz) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Ruckelshaus v. Monsanto Co.
467 U.S. 986 (Supreme Court, 1984)
H. J. Inc. v. Northwestern Bell Telephone Co.
492 U.S. 229 (Supreme Court, 1989)
Reves v. Ernst & Young
507 U.S. 170 (Supreme Court, 1993)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Reese v. BP Exploration (Alaska) Inc.
643 F.3d 681 (Ninth Circuit, 2011)
Conservation Force v. Salazar
646 F.3d 1240 (Ninth Circuit, 2011)
Fleet Credit Corporation v. Anthony Sion
893 F.2d 441 (First Circuit, 1990)